Non-Hodgkin's Lymphoma News

• IWMF 2018New Drugs Poised to Expand Treatment Horizons in WM New drug combinations and pathways continue to be mined in an effort to expand treatment horizons for control of a rare lymphoma and extend quality of life for patients over many years to come.
  Medscape Medical News, May 2018
• IWMF 2018Patience Needed: WM Is Incurable, but Survival Is Long Management of the rare lymphoma Waldenstrom's macroglobulinemia (WM) takes patience and practice to maximize longevity and keep symptoms at bay over the long haul.
  Medscape Medical News, May 2018
• Non-AIDS Cancers Expected to Dominate in HIV-infected Adults by 2030
  Reuters Health Information, May 2018
• Bortezomib-induced Neuropathic Pain a Consequence of Sphingolipid-metabolism Dysregulation
  Reuters Health Information, May 2018
• EU OK for Generic Carmustine for Brain Tumors and Lymphoma A generic version of carmustine has been recommended for approval in the European Union, as have indication extensions for several cancer drugs.
  Medscape Medical News, April 2018
• 'Landmark' Study Revises Molecular Classification of DLBCL Researchers uncover four genetic subtypes of diffuse large B-cell lymphoma with striking differences in 5-year overall survival, providing a potential path toward precision medicine treatment strategies.
  Medscape Medical News, April 2018
• AACR 2018Successful CAR T-Cell Tx Needs Good T Cells to Begin With Starting with poor-quality T cells may be a key problem in the manufacturing of effective and functional CAR T cells, which may explain why it has been difficult to apply this approach to all cancers.
  Medscape Medical News, March 2018
• FDA Panel Gives Nod to New Blincyto Use in ALL Blinatumomab would become the first treatment for which minimal residual disease positivity would be a selection criterion and MRD negativity an endpoint for acute lymphoblastic leukemia.
  Medscape Medical News, March 2018
• ECCOIBD Raises Gastrointestinal Cancer Risk Immunomodulators can intensify cancer risk in patients with bowel disease, despite their control of the underlying inflammation, and new information is emerging on the role of biologics.
  Medscape Medical News, February 2018
• CSSNo Follow-up in More Than a Third of AYA Cancer Survivors A large proportion of adolescent and young adult (AYA) cancer survivors are not receiving follow-up care after the end of their active treatment.
  Medscape Medical News, February 2018
• Young People Often Face Delays in Cancer Diagnosis Adolescents and young adults may have long delays between the onset of cancer symptoms and being diagnosed, according to data from the UK.
  Reuters Health Information, February 2018
• New CAR T Cell for Adult ALL, 'Game Changer' in Pediatric ALL A new CAR T cell has shown efficacy in adults with acute lymphoblastic leukemia (ALL), as the first of these products is hailed as a 'game changer' in pediatric ALL.
  Medscape Medical News, February 2018
• Clinical Cancer Advance of the Year Is CAR T Cells In its annual review of clinical cancer advances, the American Society of Clinical Oncology highlights CAR T cells as having 'historical significance.'
  Medscape Medical News, January 2018
• Breast Implants Tied to Increased Risk of Rare Blood Cancer Women who get breast implants may be more likely to develop anaplastic large-cell lymphoma, a small Dutch study suggests.
  Reuters Health Information, January 2018
• Call for 'Swift Action' on Blood Cancer Care in UK The earlier diagnosis of blood cancer requires greater awareness of the disease and the use of simple blood tests, say UK legislators, who call for greater integrated care and better patient support.
  Medscape Medical News, January 2018
• After Lymphoma, Risk for Breast Cancer Differs by Subtype The risk of developing estrogen-receptor-negative breast cancer following Hodgkin's lymphoma is increased regardless of prior radiotherapy.
  Medscape Medical News, January 2018
• Skin Exam Advised Before Anti-TNF-alpha Therapy Using tumor necrosis factor alpha (TNF-alpha) inhibitors for atypical dermatoses may unmask, or perhaps even worsen, cutaneous lymphoma, according to new research.
  Reuters Health Information, January 2018
• Few Patients Get CAR T Cells Because of 'Insurance Snags' Reimbursement problems related to the very high cost of therapy are causing delays in patients' receiving CAR T-cell therapy. Several experts relate their experiences.
  Medscape Medical News, January 2018
• ASHCAR T Cells: Exciting, but Who Is Going to Cover Costs? An analysis of Medicare reimbursement shows that even with a 400% markup, hospitals will be hit with a financial loss.
  Medscape Medical News, December 2017
• Physical Activity Helps Lymphoma Patients Live Longer For lymphoma patients, increasing physical activity lowers the risk of death from any cause and from lymphoma, according to results of an observational study.
  Reuters Health Information, December 2017